ISOMAP components of the hippocampus and lateral ventricles as well as CSF markers contribute to the group differences between normal controls (NC) and subjects with Alzheimer's disease (AD), NC and subjects with mild cognitive impairment (MCI), and subjects with MCI and AD.

<p>ISOMAP components of the hippocampus and lateral ventricles as well as CSF markers contribute to the group differences between normal controls (NC) and subjects with Alzheimer's disease (AD), NC and subjects with mild cognitive impairment (MCI), and subjects with MCI and AD.